NOVERA RETATRUTIDE: A NEW APPROACH FOR BODY LOSS?

Emerging clinical evidence suggests that Novera Retatrutide, a twin-action therapy from Novo Nordisk, could represent a meaningful breakthrough in body control. Beyond many existing drugs, Retatrutide affects both the GLP-1 hormone and the GIP hormone, potentially leading to enhanced reductions i